€204.60
0.39% yesterday
Paris, Jun 27, 05:35 pm CET
ISIN
FR0013154002
Symbol
DIM
Sector

Sartorius Stedim Biotech Stock price

€204.60
+10.50 5.41% 1M
+17.30 9.24% 6M
+15.90 8.43% YTD
+50.45 32.73% 1Y
-104.20 33.74% 3Y
-12.60 5.80% 5Y
+164.69 412.68% 10Y
+200.80 5,284.21% 20Y
Paris, Closing price Fri, Jun 27 2025
+0.80 0.39%
ISIN
FR0013154002
Symbol
DIM
Sector

Key metrics

Basic
Market capitalization
€19.8b
Enterprise Value
€22.0b
Net debt
€2.2b
Cash
€727.0m
Shares outstanding
97.3m
Valuation (TTM | estimate)
P/E
96.97 | 47.15
P/S
6.94 | 6.55
EV/Sales
7.71 | 7.28
EV/FCF
37.77
P/B
5.01
Dividends
DPS
€0.69
Yield 1Y | 5Y
0.34% | 0.33%
Growth 1Y | 5Y
0.00% | 15.21%
Payout 1Y | 3Y
38.12% | 19.21%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€2.9b | €3.0b
EBITDA
€710.2m | €907.6m
EBIT
€401.5m
Net Income
€204.3m | €422.2m
Free Cash Flow
€583.6m
Growth (TTM | estimate)
Revenue
5.21% | 8.92%
EBITDA
6.91% | 29.77%
EBIT
-0.84%
Net Income
-19.79% | 141.13%
Free Cash Flow
244.92%
Margin (TTM | estimate)
Gross
43.89%
EBITDA
24.85% | 29.97%
EBIT
14.05%
Net
7.15% | 13.94%
Free Cash Flow
20.42%
Financial Health
Equity Ratio
48.28%
Return on Equity
4.39%
ROCE
5.47%
ROIC
4.75%
Debt/Equity
0.74
More
EPS
€2.11
FCF per Share
€6.00
Short interest
-
Employees
9.96k
Rev per Employee
€280.00k
Show more

Is Sartorius Stedim Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Sartorius Stedim Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Sartorius Stedim Biotech forecast:

13x Buy
72%
5x Hold
28%

Analyst Opinions

18 Analysts have issued a Sartorius Stedim Biotech forecast:

Buy
72%
Hold
28%

Financial data from Sartorius Stedim Biotech

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,858 2,858
5% 5%
100%
- Direct Costs 1,603 1,603
4% 4%
56%
1,254 1,254
7% 7%
44%
- Selling and Administrative Expenses 655 655
5% 5%
23%
- Research and Development Expense 149 149
16% 16%
5%
710 710
7% 7%
25%
- Depreciation and Amortization 309 309
19% 19%
11%
EBIT (Operating Income) EBIT 402 402
1% 1%
14%
Net Profit 204 204
20% 20%
7%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius Stedim Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions and focus on single-use technologies are supporting biopharma companies around the world to develop and produce drugs safely, timely and economically. The company's product portfolio include cell analysis, cell culture media and buffers, bioreactors fermenters, lab filtration & purification, process filtration & purification, fluid management, process control & data analytics, industrial microbiology, water purification, weighing, pipetting & dispensing OEM, centrifuges and lab catalogs. Sartorius Stedim Biotech was founded in 1978 and is headquartered in Aubagne, France.

Head office France
CEO René Fáber
Employees 9,961
Founded 1978
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today